Global Insomnia Market Size study, by Treatment Type (Drug, Devices) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels) and Regional Forecasts 2022-2028

Global Insomnia Market Size study, by Treatment Type (Drug, Devices) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels) and Regional Forecasts 2022-2028

Global Insomnia Market is valued approximately USD 4.47 Billion in 2021 and is anticipated to grow with a healthy growth rate of more than 3.90 % over the forecast period 2022-2028. Insomnia is a common sleep disorder in which people have trouble sleeping, or cause to wake up early or trouble getting back to sleep. The common cause of insomnia includes stress, irregular sleep schedule, mental health disorder such as anxiety, depression. Increase in prevalence of different types of sleeping disorder such as such as insomnia and parasomnias owing to increasing stress, anxiety, depression, surge in workload are major drivers for the market. For Instance: According to the American Psychological Association's (APA) in 2021 it was found that one in three Americans (32%) said sometimes they are so stressed about the coronavirus pandemic that they struggle to make even basic decisions (e.g., what to wear, what to eat, etc.). Millennials (48%) were particularly likely to struggle with this when compared with their counterparts (Gen Z adults: 37%, Gen Xers: 32%, boomers: 14%, older adults: 3%); as were parents (47%) versus non-parents (24%). Also, Various factors such as irregular sleep schedule, usage of media devices before sleep boosting the number of people suffering from insomnia. Advancement of software assistance in mobile phones watches health and this advanced software has marked an impact in diagnosis and assistance in sleep of users. Thus, availability of these software propels the market growth. However, side effects associated with the long-term use of anti-insomnia drugs impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global Insomnia Market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America dominated Insomnia Treatment Market. Owing to growing prevalence of sleep disorders coupled with the increase in stress and growing awareness regarding available insomnia treatments. In addition, according to the American Academy of sleep medicine in 2020, stress can be a factor resulting in insomnia which affects up to 20% Americans every year is contributing in favor of Insomnia Treatment Market

Major market player included in this report are:
Pfizer Inc.
Sanofi S.A.
Takeda Pharmaceutical Company Ltd.
Merck & Co., Inc
Electromedical Products International, Inc.
Currax Pharmaceuticals LLC
Eisai Co., Ltd.
Minerva Neurosciences, Inc.Vanda Pharmaceuticals Inc.
Viatris Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:
By Treatment Type:
Drug
Devices
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Other Distribution Channels
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Insomnia Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Pfizer Inc.
Sanofi S.A.
Takeda Pharmaceutical Company Ltd.
Merck & Co., Inc
Electromedical Products International, Inc.
Currax Pharmaceuticals LLC
Eisai Co., Ltd.
Minerva Neurosciences, Inc.Vanda Pharmaceuticals Inc.
Viatris Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.